12:00 AM
Oct 21, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Feraheme ferumoxytol regulatory update

AMAG said FDA extended the PDUFA date by 3 months for an sNDA to expand the indication of Feraheme ferumoxytol to include the treatment of all adult patients with iron deficiency anemia who have failed or could not tolerate oral iron treatment. The new date is Jan. 21, 2014;...

Read the full 222 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >